U.S. Markets close in 3 hrs 52 mins

GenMark Diagnostics: 2Q Earnings Snapshot

CARLSBAD, Calif. (AP) _ GenMark Diagnostics Inc. (GNMK) on Monday reported a loss of $13.3 million in its second quarter.

The Carlsbad, California-based company said it had a loss of 23 cents per share.

The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 21 cents per share.

The molecular diagnostics company posted revenue of $18.4 million in the period, which topped Street forecasts. Four analysts surveyed by Zacks expected $17.9 million.

GenMark Diagnostics expects full-year revenue in the range of $85 million to $90 million.

GenMark Diagnostics shares have risen 18% since the beginning of the year. In the final minutes of trading on Monday, shares hit $5.74, a fall of 21% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GNMK at https://www.zacks.com/ap/GNMK